GAP:NYSEGap, Inc. (The) Analysis
Data as of 2026-04-05 - not real-time
$24.61
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gap reported a modest 2% increase in net sales and a 3% rise in comparable sales for Q4 FY2025, delivering an operating margin of 7.3% that beat its outlook and generating $1.3 billion of operating cash flow, while authorizing a $1 billion share‑repurchase program. The stock trades at $24.61, which is above the DCF‑derived fair value of $20.88, implying roughly a 24% valuation premium, yet analysts’ consensus target of $31 suggests an additional upside of about 25%. Technically, the price sits just above the 20‑day SMA (24.04) and the MACD histogram is positive, indicating a bullish tilt, while the RSI of 46.8 points to a neutral momentum environment. Valuation metrics such as a trailing PE of 11.6 and forward PE of 9.4 position Gap as a value‑oriented play, though the high beta (~1.2) and 30‑day volatility of 57% underscore price sensitivity. The dividend yield of 2.84% with a 31% payout ratio appears sustainable given strong free cash flow and a solid ROE of 23%. However, a debt‑to‑equity ratio of 148% and decreasing volume signal heightened financial and liquidity risk. Overall, the stock offers a blend of modest growth, attractive yield, and upside potential, but investors should weigh the elevated volatility and leverage before committing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Earnings beat and strong cash flow
- Neutral technical stance near resistance
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst target price implying ~25% upside
- Sustainable dividend yield
- Share‑repurchase program supporting price
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Diversified brand portfolio with steady earnings
- Attractive valuation relative to peers
- Long‑term cash generation despite leverage
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin5.31%
P/E Ratio11.6
ROE23.10%
ROA5.62%
Debt/Equity147.62
P/B Ratio2.4
Op. Cash Flow$1.3B
Free Cash Flow$701.2M
Technical Analysis
TrendNeutral
RSI46.8
Support$22.03
Resistance$25.84
MA 20$24.04
MA 50$26.26
MA 200$23.95
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8
Valuation
Fair Value$20.88
Target Price$30.65
Upside/Downside24.55%
GradeFair
TypeBlend
Dividend Yield2.84%
Risk Assessment
Beta1.17
Volatility57.45%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.